Literature DB >> 9382052

Fundic gland polyps developing during omeprazole therapy.

H M el-Zimaity1, F W Jackson, D Y Graham.   

Abstract

OBJECTIVE: Side effects of omeprazole therapy include reversible hypergastrinemia, entero chromaffin-like hyperplasia, and possibly acceleration of atrophic gastritis in the gastric corpus in patients with Helicobacter pylori infection. The objective of this report is to describe six cases of fundic gland polyps that developed while omeprazole was being used for Barrett's esophagus.
METHODS: Three women and three men developed fundic gland polyps after 1-5 yr of omeprazole therapy, 20 mg/day. In the index case, fundal polyps developed after 2 yr of continuous omeprazole therapy. Omeprazole was stopped, but because of poor clinical efficacy with H2-blockers, it was reinstated.
RESULTS: After 4 yr of therapy, multiple large fundal polyps were present. Histology of all lesions revealed characteristic fundal gland polyps with multiple cystic dilations. None of the patients had H. pylori infection. Serum gastrin was normal in four and slightly increased in two.
CONCLUSION: These cases support the possible causal relation between the use of omeprazole and the development of fundic gland polyps in patients without H. pylori gastritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9382052

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  34 in total

Review 1.  Safety of the long-term use of proton pump inhibitors.

Authors:  Alan B R Thomson; Michel D Sauve; Narmin Kassam; Holly Kamitakahara
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

2.  Gastric polyps: a review of clinical, endoscopic, and histopathologic features and management decisions.

Authors:  Rafiul Sameer Islam; Neal C Patel; Dora Lam-Himlin; Cuong C Nguyen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-10

3.  Proton pump inhibitors: use, misuse and concerns about long-term therapy.

Authors:  T P Rakesh
Journal:  Clin J Gastroenterol       Date:  2011-02-18

4.  Benign Blockage: Gastric Outlet Obstruction due to a Prolapsing Gastric Pedunculated Polyp-Case Report and Literature Review.

Authors:  N Zorzetti; A Lauro; V D'Andrea; A Ruffato; L Ferruzzi; N Antonacci; R M Tranchino
Journal:  Dig Dis Sci       Date:  2021-02-26       Impact factor: 3.199

5.  Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene.

Authors:  Susan C Abraham; Seun Ja Park; Lilian Mugartegui; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 6.  Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.

Authors:  Jeong Soo Ahn; Chun-Sick Eom; Christie Y Jeon; Sang Min Park
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

7.  Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies.

Authors:  Adriana Zelter; José Luis Fernández; Claudio Bilder; Pablo Rodríguez; Andrés Wonaga; Fernanda Dorado; Miriam Galich; Luis Alberto Viola
Journal:  Dig Dis Sci       Date:  2010-12-03       Impact factor: 3.199

Review 8.  Management of gastric polyps: an endoscopy-based approach.

Authors:  Yasser H Shaib; Massimo Rugge; David Y Graham; Robert M Genta
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-10       Impact factor: 11.382

9.  A case of autoimmune gastritis with fundic gland polyp-like pseudopolyps presenting with nodular enterochromaffin-like cell hyperplasia.

Authors:  Tohru Kotera; Takahiro Takemoto; Ryoji Kushima; Ken Haruma
Journal:  Clin J Gastroenterol       Date:  2020-11-20

10.  Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps.

Authors:  Mazer R Ally; Ganesh R Veerappan; Corinne L Maydonovitch; Timothy J Duncan; Joseph L Perry; Eric M Osgard; Roy K H Wong
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.